Description:
The Immuno Candida test is designed to detect precipitating antibodies to the infectious fungus Candida.


The Candida Immunodiffusion test is an FDA approved procedure to detect precipitating antibodies to both Candida cytoplasmic and mannan antigen fractions. Agarose gel is used to reveal bands of precipitating antibodies (if present) in the patient's serum. Test results are reported as negative or positive; if positive, the number of bands is reported. The ELISA test offers high sensitivity and specificity in detecting early stage Polysystemic Chronic Candidiasis (P.C.C.) allowing prompt initiation of therapy. The Immunodiffusion test confirms late stage P.C.C. when antibody levels have risen significantly. Both tests are run on each patient sample.


A form of Candidiasis has emerged which manifests symptoms that are often systemic and cause considerable discomfort. It usually originates as an overgrowth of the fungal form of Candida occurring in the lower gastrointestinal tract. Frequent use of steroid and antibiotic medications, oral contraceptives and diets high in yeast-containing foods, sugars, and refined carbohydrates are all known to stimulate Candida overgrowth.
Tests for:
Candida infections


Symptoms and conditions:
  • Headaches
  • Depression
  • Sleep problems
  • Irritability
  • Confusion
  • Poor memory
  • Anxiety
  • Obsessive-compulsive disorder (OCD)
  • Irregular heart beat
  • Sexual problems
  • Attention deficit, hyperactivity (ADD/ADHD)
  • Dizziness
  • Numbness


Method:
ELISA
candida_sr_immuno_950__1_.pdf
File Size: 104 kb
File Type: pdf
Hämta fil